Podcasts about Tandem

This week we discuss another tragedy in cycling with the death of Finlay Tarling. We preview the highly contested grey jersey competition at the upcoming Vuelta and take a much-loved brand in an unexpected direction.  Find us, and other fantastic cycling podcasts on the Wide Angle Podium Network, at wideanglepodium.com! Check out the brand new WAP app available in the Apple and Android app stores! You can email us at theslowridepodcast@gmail.com

Die Accell-Gruppe ist in der Krise und die Fahrradindustrie steht vor großen Herausforderungen. Wie umgehen mit neuer Konkurrenz aus China? (00:00:00) Ultrasandalen und Rückblick auf die Tour de France Femmes (00:10:10) Dirk Zedler zur Krise der Accell-Gruppe (00:16:13) Was die Insolvenz für Marken und Händler bedeutet (00:26:28) Die drei großen Gefahren für die Fahrradindustrie (00:29:43) Chinas Fünfjahresplan für die Fahrradwirtschaft (00:35:10) Wissenstransfer, Zölle und Direktkauf aus China (00:46:13) Sorge um den Mittelstand (00:55:28) Ein positives Szenario? (01:01:32) Outro: Subventionen, Solarindustrie und Klumpenrisiko (01:14:13) MUSIK: Blonde Redhead – Blood Spilled Hier geht’s zu unserem Gespräch mit Dirk Zedler zum Verkaufsstopp und Rückruf bei Babboe: https://detektor.fm/gesellschaft/antritt-verkaufsstopp-und-rueckruf-bei-babboe-game-of-toiletpaper-mit-regine Hier geht’s zum Gespräch mit Arne Bischoff über Gefahren für das E-Bike: https://detektor.fm/gesellschaft/antritt-arne-bischoff-ueber-die-zukunft-des-e-bikes Hier geht’s zum Instagram-Account the.european.bike.project: https://www.instagram.com/the.european.bike.project/ Hier geht’s zu unserer Playlist auf Spotify: https://open.spotify.com/playlist/0rFFrMDgoZX2PdHMwvaEmG?si=8w56NndiQQikVzEDcWtjNg Hier gibt’s Tickets für unseren Live-Podcast am 9.10. in der Schicken Mütze in Düsseldorf: https://www.zoon-podcast-week.de/podcast/antritt Hier gibt’s Tickets für unseren Live-Podcast am 7.11. in der Scheune in Dresden: https://scheune.org/show/5668/antritt-der-fahrradpodcast.html Hier könnt ihr uns bei Steady unterstützen: https://steadyhq.com/de/antritt/about Hier entlang geht's zu den Links unserer Werbepartner: https://detektor.fm/werbepartner/antritt ➡️ Artikel zum Nachlesen: https://detektor.fm/gesellschaft/antritt-dirk-zedler-ueber-accell-krise-und-gefahren-fuer-die-fahrradwirtschaft

Die Accell-Gruppe ist in der Krise und die Fahrradindustrie steht vor großen Herausforderungen. Wie umgehen mit neuer Konkurrenz aus China? (00:00:00) Ultrasandalen und Rückblick auf die Tour de France Femmes (00:10:10) Dirk Zedler zur Krise der Accell-Gruppe (00:16:13) Was die Insolvenz für Marken und Händler bedeutet (00:26:28) Die drei großen Gefahren für die Fahrradindustrie (00:29:43) Chinas Fünfjahresplan für die Fahrradwirtschaft (00:35:10) Wissenstransfer, Zölle und Direktkauf aus China (00:46:13) Sorge um den Mittelstand (00:55:28) Ein positives Szenario? (01:01:32) Outro: Subventionen, Solarindustrie und Klumpenrisiko (01:14:13) MUSIK: Blonde Redhead – Blood Spilled Hier geht’s zu unserem Gespräch mit Dirk Zedler zum Verkaufsstopp und Rückruf bei Babboe: https://detektor.fm/gesellschaft/antritt-verkaufsstopp-und-rueckruf-bei-babboe-game-of-toiletpaper-mit-regine Hier geht’s zum Gespräch mit Arne Bischoff über Gefahren für das E-Bike: https://detektor.fm/gesellschaft/antritt-arne-bischoff-ueber-die-zukunft-des-e-bikes Hier geht’s zum Instagram-Account the.european.bike.project: https://www.instagram.com/the.european.bike.project/ Hier geht’s zu unserer Playlist auf Spotify: https://open.spotify.com/playlist/0rFFrMDgoZX2PdHMwvaEmG?si=8w56NndiQQikVzEDcWtjNg Hier gibt’s Tickets für unseren Live-Podcast am 9.10. in der Schicken Mütze in Düsseldorf: https://www.zoon-podcast-week.de/podcast/antritt Hier gibt’s Tickets für unseren Live-Podcast am 7.11. in der Scheune in Dresden: https://scheune.org/show/5668/antritt-der-fahrradpodcast.html Hier könnt ihr uns bei Steady unterstützen: https://steadyhq.com/de/antritt/about Hier entlang geht's zu den Links unserer Werbepartner: https://detektor.fm/werbepartner/antritt ➡️ Artikel zum Nachlesen: https://detektor.fm/gesellschaft/antritt-dirk-zedler-ueber-accell-krise-und-gefahren-fuer-die-fahrradwirtschaft

Die Accell-Gruppe ist in der Krise und die Fahrradindustrie steht vor großen Herausforderungen. Wie umgehen mit neuer Konkurrenz aus China? (00:00:00) Ultrasandalen und Rückblick auf die Tour de France Femmes (00:10:10) Dirk Zedler zur Krise der Accell-Gruppe (00:16:13) Was die Insolvenz für Marken und Händler bedeutet (00:26:28) Die drei großen Gefahren für die Fahrradindustrie (00:29:43) Chinas Fünfjahresplan für die Fahrradwirtschaft (00:35:10) Wissenstransfer, Zölle und Direktkauf aus China (00:46:13) Sorge um den Mittelstand (00:55:28) Ein positives Szenario? (01:01:32) Outro: Subventionen, Solarindustrie und Klumpenrisiko (01:14:13) MUSIK: Blonde Redhead – Blood Spilled Hier geht’s zu unserem Gespräch mit Dirk Zedler zum Verkaufsstopp und Rückruf bei Babboe: https://detektor.fm/gesellschaft/antritt-verkaufsstopp-und-rueckruf-bei-babboe-game-of-toiletpaper-mit-regine Hier geht’s zum Gespräch mit Arne Bischoff über Gefahren für das E-Bike: https://detektor.fm/gesellschaft/antritt-arne-bischoff-ueber-die-zukunft-des-e-bikes Hier geht’s zum Instagram-Account the.european.bike.project: https://www.instagram.com/the.european.bike.project/ Hier geht’s zu unserer Playlist auf Spotify: https://open.spotify.com/playlist/0rFFrMDgoZX2PdHMwvaEmG?si=8w56NndiQQikVzEDcWtjNg Hier gibt’s Tickets für unseren Live-Podcast am 9.10. in der Schicken Mütze in Düsseldorf: https://www.zoon-podcast-week.de/podcast/antritt Hier gibt’s Tickets für unseren Live-Podcast am 7.11. in der Scheune in Dresden: https://scheune.org/show/5668/antritt-der-fahrradpodcast.html Hier könnt ihr uns bei Steady unterstützen: https://steadyhq.com/de/antritt/about Hier entlang geht's zu den Links unserer Werbepartner: https://detektor.fm/werbepartner/antritt ➡️ Artikel zum Nachlesen: https://detektor.fm/gesellschaft/antritt-dirk-zedler-ueber-accell-krise-und-gefahren-fuer-die-fahrradwirtschaft

Scott Wharton, CEO of Tandem PV, discusses his company's tandem perovskite silicon solar panel technology, which recently achieved a record 30.4 percent efficiency. He explains how a thin perovskite layer boosts power output, lowers manufacturing costs, and supports domestic production. The conversation also covers utility scale deployment, rising demand from data centers, manufacturing tax credits, and the future of solar energy in the United States.   Topics Covered Tandem PV Origin Perovskite Technology Solar Panel Efficiency Silicon Cell Integration Company Board Members                                                                    Panel Degradation Testing Solar Manufacturing Timeline Utility-Scale Solar Silicon Valley Talent US Manufacturing Tax Credits Data Center Demand Solar Cost Reduction Bifacial Solar Panels Automated Factory Production Future Efficiency Roadmap PV = Photovoltaic IPP = Independent Power Producer SEIA = Solar Energy Industries Association IRA = Inflation Reduction Act Podcast with Dick Swanson Apple Podcast YouTube Spotify Pandora Podbean   Reach out to Scott Wharton here: LinkedIn: www.linkedin.com/in/scottwharton/ Website: www.tandempv.com/ Email: scott@tandempv.com   Learn more at www.solarSEAN.com and be sure to get NABCEP certified by taking Sean's classes at www.heatspring.com/sean www.solarsean.com/esip

In 2020, Teri and her husband got on a tandem bike in Oregon and got off in Washington DC. Well, they got on and off a few times between the two, but you know what I mean. It was a 3102 mile journey, and most impressively, they didn't get hit by a single car. They came pretty close one time, though.For more of Teri's story, or to check out her books, visit https://www.terimbrown.com/!This guest was booked using PodMatch! Interested in being a guest on the show? Reach out to us at https://www.podmatch.com/member/tombarnardpodcast.

2empujandolimites es el nombre de la asociación civil fundada por Juan Zemborain, padre de Santiago. Su ejemplo inspira y moviliza a miles de padres e hijos a pedalear en tándem. Escuchen esta #HistoriaMinima que los va a emocionar tanto como a nosotras.Sumate al programa y si te gustó esta nota, compartila!www.citasderadio.com.arEp. 234 - T.6

Die Maus zum Hören - Lach - und Sachgeschichten: Heute: mit Fahrrädern für zwei, Helmen und ihren Löchern, einem Fahrrad als Instrument, mit Verena und natürlich mit der Maus und dem Elefanten. Ihr hört eine Wiederholung. Wortschatzkiste: Tandem (06:56) Frage des Tages: Warum heißt die Draisine "Draisine"? (15:44) Hörspiel: Cleo Fischer - Rache (22:29) Ein Fahrrad als Musikinstrument (32:49) Reportage: Beim Rennradtraining (39:35) Warum hat ein Fahrradhelm Löcher? (48:35) Von Verena Specks-Ludwig.

It was a very successful 2026 Commonwealth Games for New Zealand's tandem cyclists at the Sir Chris Hoy Velodrome in Glasgow.RNIB Connect Radio's Allan Russell spoke to Emma and Jess, as they celebrated a Gold double.#RNIBConnectImage Shows RNIB Connect Radio Logo, White Background, RNIB In Bold Black Letters, A Solid Pink Line Below With Connect Radio Underneath

After a 4th place in the Women's Tandem Pursuit, at the Glasgow Commonwealth GamesEngland's Sophie Unwin and her pilot Anna, scooped Bronze in the Kilo.RNIB Connect Radio's Allan Russell spoke with them as the games drew to a close.#RNIBConnectImage Shows RNIB Connect Radio Logo, White Background, RNIB In Bold Black Letters, A Solid Pink Line Below With Connect Radio Underneath.

Ein Teil unseres Pelotons ist zum „Antritt“-Treffen nach Leipzig gereist. Es gab viel Austausch rund ums Rad und zur Fahrradzukunft. (00:00:00) Intro (00:00:43) Review: Tour de France (00:11:51) Rückblick zum Hörertreffen (00:18:27) Wünsche für das Fahrrad – Hörertreffen-Edition (00:41:22) Zurück ins Studio (00:41:51) Unterstützer*in werden (00:46:23) Christians erster Triathlon (00:50:27) Rennen Insights (01:02:06) Song: Disclosure – You & Me (Flume Remix) Hier geht’s zum Live-Podcast mit Martin Goetze: https://detektor.fm/gesellschaft/antritt-martin-goetze-ueber-radsport-in-der-ddr Hier geht’s zur Ausgabe vom ersten „Antritt“-Treffen im Juni 2025: https://detektor.fm/gesellschaft/antritt-rueckblick-auf-das-erste-antritt-treffen Hier geht’s zum Gespräch mit Hanka Kupfernagel vom Juni 2025: https://detektor.fm/gesellschaft/antritt-hanka-kupfernagel-ueber-querfeldein-frauenradsport-und-ihre-karriere Hier geht’s zu unserer Playlist auf Spotify: https://open.spotify.com/playlist/0rFFrMDgoZX2PdHMwvaEmG?si=8w56NndiQQikVzEDcWtjNg Hier gibt’s Tickets für unseren Live-Podcast am 9.10. in der Schicken Mütze in Düsseldorf: https://www.zoon-podcast-week.de/podcast/antritt Hier gibt’s Tickets für unseren Live-Podcast am 7.11. in der Scheune in Dresden: https://scheune.org/show/5668/antritt-der-fahrradpodcast.html Hier könnt ihr uns bei Steady unterstützen: https://steadyhq.com/de/antritt/about Hier entlang geht's zu den Links unserer Werbepartner: https://detektor.fm/werbepartner/antritt ➡️ Artikel zum Nachlesen: https://detektor.fm/gesellschaft/antritt-antritt-treffen-tour-de-france-und-triathlon

Ein Teil unseres Pelotons ist zum „Antritt“-Treffen nach Leipzig gereist. Es gab viel Austausch rund ums Rad und zur Fahrradzukunft. (00:00:00) Intro (00:00:43) Review: Tour de France (00:11:51) Rückblick zum Hörertreffen (00:18:27) Wünsche für das Fahrrad – Hörertreffen-Edition (00:41:22) Zurück ins Studio (00:41:51) Unterstützer*in werden (00:46:23) Christians erster Triathlon (00:50:27) Rennen Insights (01:02:06) Song: Disclosure – You & Me (Flume Remix) Hier geht’s zum Live-Podcast mit Martin Goetze: https://detektor.fm/gesellschaft/antritt-martin-goetze-ueber-radsport-in-der-ddr Hier geht’s zur Ausgabe vom ersten „Antritt“-Treffen im Juni 2025: https://detektor.fm/gesellschaft/antritt-rueckblick-auf-das-erste-antritt-treffen Hier geht’s zum Gespräch mit Hanka Kupfernagel vom Juni 2025: https://detektor.fm/gesellschaft/antritt-hanka-kupfernagel-ueber-querfeldein-frauenradsport-und-ihre-karriere Hier geht’s zu unserer Playlist auf Spotify: https://open.spotify.com/playlist/0rFFrMDgoZX2PdHMwvaEmG?si=8w56NndiQQikVzEDcWtjNg Hier gibt’s Tickets für unseren Live-Podcast am 9.10. in der Schicken Mütze in Düsseldorf: https://www.zoon-podcast-week.de/podcast/antritt Hier gibt’s Tickets für unseren Live-Podcast am 7.11. in der Scheune in Dresden: https://scheune.org/show/5668/antritt-der-fahrradpodcast.html Hier könnt ihr uns bei Steady unterstützen: https://steadyhq.com/de/antritt/about Hier entlang geht's zu den Links unserer Werbepartner: https://detektor.fm/werbepartner/antritt ➡️ Artikel zum Nachlesen: https://detektor.fm/gesellschaft/antritt-antritt-treffen-tour-de-france-und-triathlon

「「有機EL vs 液晶」論争再燃!? LGディスプレイ「Tandem WOLED」説明会で明かされたOLEDの強みと歩み」　LGディスプレイ・ジャパンは7月30日、メディア向けに有機ELディスプレイの最新動向を紹介する「メディアデー」を開催した。テレビ用有機ELディスプレイの市場動向や、2026年世代の「Tandem WOLED」に採用した技術などを説明した。

Ein Teil unseres Pelotons ist zum „Antritt“-Treffen nach Leipzig gereist. Es gab viel Austausch rund ums Rad und zur Fahrradzukunft. (00:00:00) Intro (00:00:43) Review: Tour de France (00:11:51) Rückblick zum Hörertreffen (00:18:27) Wünsche für das Fahrrad – Hörertreffen-Edition (00:41:22) Zurück ins Studio (00:41:51) Unterstützer*in werden (00:46:23) Christians erster Triathlon (00:50:27) Rennen Insights (01:02:06) Song: Disclosure – You & Me (Flume Remix) Hier geht’s zum Live-Podcast mit Martin Goetze: https://detektor.fm/gesellschaft/antritt-martin-goetze-ueber-radsport-in-der-ddr Hier geht’s zur Ausgabe vom ersten „Antritt“-Treffen im Juni 2025: https://detektor.fm/gesellschaft/antritt-rueckblick-auf-das-erste-antritt-treffen Hier geht’s zum Gespräch mit Hanka Kupfernagel vom Juni 2025: https://detektor.fm/gesellschaft/antritt-hanka-kupfernagel-ueber-querfeldein-frauenradsport-und-ihre-karriere Hier geht’s zu unserer Playlist auf Spotify: https://open.spotify.com/playlist/0rFFrMDgoZX2PdHMwvaEmG?si=8w56NndiQQikVzEDcWtjNg Hier gibt’s Tickets für unseren Live-Podcast am 9.10. in der Schicken Mütze in Düsseldorf: https://www.zoon-podcast-week.de/podcast/antritt Hier gibt’s Tickets für unseren Live-Podcast am 7.11. in der Scheune in Dresden: https://scheune.org/show/5668/antritt-der-fahrradpodcast.html Hier könnt ihr uns bei Steady unterstützen: https://steadyhq.com/de/antritt/about Hier entlang geht's zu den Links unserer Werbepartner: https://detektor.fm/werbepartner/antritt ➡️ Artikel zum Nachlesen: https://detektor.fm/gesellschaft/antritt-antritt-treffen-tour-de-france-und-triathlon

It was a well deserved Bronze for para cyclists Lizzi Jordon and her Pilot Sylvia at their first event of the Commonwealth Games in Glasgow.RNIB Connect Radio's Allan Russell spoke to them after the medals ceremony…#RNIBConnectImage Shows RNIB Connect Radio Logo, White Background, RNIB In Bold Black Letters, A Solid Pink Line Below With Connect Radio Underneath

In this episode of Ask Dubey, Devan Dubnyk answers your biggest Edmonton Oilers questions before announcing an exciting new chapter for the show.Dubey breaks down the Oilers' revamped goaltending tandem featuring Frederik Andersen and Tristan Jarry, explains why Edmonton's new setup could help both netminders succeed, and shares why he still believes Devin Levi has the potential to become a high-end NHL goalie.He also gives his honest thoughts on Mike Babcock becoming the Oilers' head coach, discussing why the organization felt confident in the hire, the importance of earning a second chance, and whether Babcock can adapt his coaching style in today's NHL.To wrap things up, Dubey opens up about life after hockey, revealing what retirement has really been like, the challenge of losing the structure of professional sports, and how coaching, family, and new passions have helped him find purpose after his playing career.In this episode:Exciting news about the future of Ask DubeyWhy Frederik Andersen was the right additionTristan Jarry's role in Edmonton's tandemCan Devin Levi still become an NHL starter?Devan's thoughts on Mike BabcockLife after retirement and finding a new purpose

Tandem revenimus! De Rusticatione et praecipue de cibis ab archimageiro nostro Iosue parati etenim de amicitia.

In this episode of Ask Dubey, Devan Dubnyk answers your biggest Edmonton Oilers questions before announcing an exciting new chapter for the show.Dubey breaks down the Oilers' revamped goaltending tandem featuring Frederik Andersen and Tristan Jarry, explains why Edmonton's new setup could help both netminders succeed, and shares why he still believes Devin Levi has the potential to become a high-end NHL goalie.He also gives his honest thoughts on Mike Babcock becoming the Oilers' head coach, discussing why the organization felt confident in the hire, the importance of earning a second chance, and whether Babcock can adapt his coaching style in today's NHL.To wrap things up, Dubey opens up about life after hockey, revealing what retirement has really been like, the challenge of losing the structure of professional sports, and how coaching, family, and new passions have helped him find purpose after his playing career.In this episode:Exciting news about the future of Ask DubeyWhy Frederik Andersen was the right additionTristan Jarry's role in Edmonton's tandemCan Devin Levi still become an NHL starter?Devan's thoughts on Mike BabcockLife after retirement and finding a new purpose

When conflict arises, does one of you tend to get aggressive, and does the other withdraw? Dr. Josh and Christi Straub talk with Jim and Jean Daly about how to recognize your patterns in conflict and how you can handle arguments in a more constructive way. Plus, Greg and Erin offer some helpful advice on how to recognize if you're playing the victim in marital conflict. Find us online at focusonthefamily.com/marriagepodcast or call 1-800-A-FAMILYFamous at HomeFocus on Marriage AssessmentBecoming Teammates in Marriage I-II (Digital)Take the Reactive Cycle AssessmentCounseling Consultation and Referrals

When conflict arises, does one of you tend to get aggressive, and does the other withdraw? Dr. Josh and Christi Straub talk with Jim and Jean Daly about how to recognize your patterns in conflict and how you can handle arguments in a more constructive way. Plus, Greg and Erin offer some helpful advice on how to recognize if you're playing the victim in marital conflict. Find us online at focusonthefamily.com/marriagepodcast or call 1-800-A-FAMILYFamous at HomeFocus on Marriage AssessmentBecoming Teammates in Marriage I-II (Digital)Take the Reactive Cycle AssessmentCounseling Consultation and Referrals To support this ministry financially, visit: https://www.oneplace.com/donate/1196/29?v=20251111

Elle a grandi dans un hôtel particulier entouré d'un vaste parc, à Saint-Cloud, ville privilégiée aux portes de Paris. Lui dans un logement social en Seine-Saint-Denis, l'un des départements les plus pauvres de France. Elle défend les ouvriers, les petites classes moyennes, lui aime l'entreprenariat, et cultive les relations avec les élites économiques. Et tous deux sont d'extrême droite. Marine Le Pen et Jordan Bardella, te tandem du Rassemblement national pour l'élection présidentielle de 2027, caracolent en tête des sondages. Déjà trois fois candidate, Marine Le Pen, 57 ans, vient d'annoncer qu'elle se représentera une quatrième fois. Elle a été condamnée par la Cour d'appel de Paris dans l'affaire de détournements de fonds du Parlement européen qui la visait tout comme dix autres prévenus, mais la peine infligée, plus clémente qu'en première instance, lui permet de se présenter. Le président du parti Jordan Bardella, qui se préparait à seulement 30 ans à revêtir le costume de candidat, doit pour l'instant renoncer en échange d'un potentiel poste de Premier ministre. Après l'annonce, Marine Le Pen a repris sa place en haut des sondages, à neuf mois de la présidentielle qui se tiendra les 18 avril et 2 mai 2027. Mais pour s'y maintenir, il faudra d'abord que le duo formé avec Jordan Bardella fonctionne et qu'ils surmontent les divergences de fond qui sont apparues. Pour cet épisode préparé avec Emmanuelle Baillon, nous vous proposons une conversation avec Gabriel Bourovitch, qui suit l'extrême droite au service politique de l'AFP.Réalisation : Emmanuelle Baillon et Michaëla Cancela-KiefferSons de terrain : AFPTVMusique : Michael LiotIntervenants :Louis Aliot, vice-président du Rassemblement nationalGilles Ovaldi, chargé de recherche au CNRS et au sein du Centre pour l'étude de la vie politque française (CEVIPOF) de Sciences Po.La Semaine sur le Fil est le podcast hebdomadaire de l'AFP. Vous avez des commentaires ? Ecrivez-nous à podcast@afp.com . Si vous aimez, abonnez-vous, parlez de nous autour de vous et laissez-nous plein d'étoiles sur votre plateforme de podcasts préférée pour mieux faire connaître notre programme. Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

Christian hat die Tour de France am Tourmalet erlebt und Lucas macht Dienstreisen jetzt mit Zug und Fahrrad. (00:00:00) Begrüßung (00:01:28) Per E-Auto zur Tour (00:12:17) Christian will in die Pyrenäen (00:16:12) Der Tag der Tourmalet-Etappe (00:24:48) Die Werbekarawane (00:30:00) Die Helis kommen (00:35:19) Was zieht die Leute zur Tour? (00:37:58) Lucas' Dienstreise (00:42:53) Gibt es Nachteile? (00:47:50) Wie zufrieden ist Lucas mit der Bahn? (00:54:20) Wie geht’s weiter? (00:56:10) Verabschiedung (00:57:30) Sommerregen – Kitschkrieg feat. Milleniumkid & Domiziana Hier geht’s zum Artikel bei Escape Collective über die Fahrzeuge der Werbekarawane: https://escapecollective.com/a-drivtour-de-france-caravan-vehicles-of-years-past/ Hier geht’s zu unserer Playlist auf Spotify: https://open.spotify.com/playlist/0rFFrMDgoZX2PdHMwvaEmG?si=8w56NndiQQikVzEDcWtjNg Hier könnt ihr uns bei Steady unterstützen: https://steadyhq.com/de/antritt/about Hier entlang geht's zu den Links unserer Werbepartner: https://detektor.fm/werbepartner/antritt ➡️ Artikel zum Nachlesen: https://detektor.fm/gesellschaft/antritt-christian-zur-tour-am-tourmalet-und-lucas-auf-dienstreise

Christian hat die Tour de France am Tourmalet erlebt und Lucas macht Dienstreisen jetzt mit Zug und Fahrrad. (00:00:00) Begrüßung (00:01:28) Per E-Auto zur Tour (00:12:17) Christian will in die Pyrenäen (00:16:12) Der Tag der Tourmalet-Etappe (00:24:48) Die Werbekarawane (00:30:00) Die Helis kommen (00:35:19) Was zieht die Leute zur Tour? (00:37:58) Lucas' Dienstreise (00:42:53) Gibt es Nachteile? (00:47:50) Wie zufrieden ist Lucas mit der Bahn? (00:54:20) Wie geht’s weiter? (00:56:10) Verabschiedung (00:57:30) Sommerregen – Kitschkrieg feat. Milleniumkid & Domiziana Hier geht’s zum Artikel bei Escape Collective über die Fahrzeuge der Werbekarawane: https://escapecollective.com/a-drivtour-de-france-caravan-vehicles-of-years-past/ Hier geht’s zu unserer Playlist auf Spotify: https://open.spotify.com/playlist/0rFFrMDgoZX2PdHMwvaEmG?si=8w56NndiQQikVzEDcWtjNg Hier könnt ihr uns bei Steady unterstützen: https://steadyhq.com/de/antritt/about Hier entlang geht's zu den Links unserer Werbepartner: https://detektor.fm/werbepartner/antritt ➡️ Artikel zum Nachlesen: https://detektor.fm/gesellschaft/antritt-christian-zur-tour-am-tourmalet-und-lucas-auf-dienstreise

Welcome to our July Breastfeeding Q&A episode! We open with a conversation about what surprised women most about breastfeeding (for better or worse) after all the things they'd heard from others, from pain and emotional shifts to supply, pumping, and expectations that didn't match reality.Additionally, we answer the following questions:I'm pregnant and still breastfeeding my toddler. What should I know about tandem nursing, and how do I prioritize a newborn without creating oversupply?My newborn had low blood sugar readings in the hospital and we were encouraged to use donor milk. Was that necessary, and would things have resolved differently outside that setting?I experience waves of anxiety, nausea, and sadness right before letdown. What is this and is it normal?As usual, we lead into a round of quickies including: can latch change during teething, how to manage nipple sensitivity during your cycle, does milk supply drop when baby starts sleeping longer stretches, should you always nurse from both sides, is one breast doing all the work okay, do breastfed babies need vitamin D, and when is it okay for baby to sleep through the night. We wrap with a personal question which is: What advice would you give to someone entering the industry?#364 | When Co-Sleeping Gets Complicated: Weaning, Toddlers, and Sleep Transitions with Tiffany BelangerSend us Fan Mail Support the showAccess our workshops: Have a Physiologic Birth in the Hospital and Ultrasound: The Research vs RhetoricNeeded

"Am Anfang war da so viel Feuerwerk." "Irgendwann wird das halt weniger." "So ist das halt in Beziehungen." Diese Sätze kennen wir alle. Aber was, wenn das nur ein einziges Narrativ von vielen ist? Diese Folge ist eine Fokusfolge – das bedeutet, das Gespräch existiert bereits in voller Länge, wurde hier aber neu aufbereitet und auf die wertvollsten Erkenntnisse destilliert, damit du das Wesentliche kompakt und direkt mitnehmen kannst. In dieser Folge lade ich die Paartherapeutin Dr.Sharon Brehm in meine Sprechstunde ein und wir reden über die Fragen, die sich die meisten von uns stellen, aber selten laut aussprechen. Wie halte ich Leidenschaft und Intimität lebendig? Was steckt wirklich hinter Eifersucht? Wie erreiche ich meinen Partner, wenn er sich hinter einer Mauer versteckt? Und: Bin ich überhaupt beziehungsfähig? Leidenschaft verschwindet nicht einfach. Sie wartet darauf, neu entdeckt zu werden. Was du unter Romantik verstehst, ist vielleicht etwas völlig anderes als das deines Partners. Kerzen. Tiefe Gespräche. Körperliche Nähe. Und genau da fängt das echte Gespräch an – nicht das Ende. Eifersucht ist kein Feind. Sie ist ein Hinweis. Ein Zeichen dafür, dass dir jemand wichtig ist. Dass du Nähe willst. Dass du gesehen werden möchtest. Ich kann nicht auf etwas eifersüchtig sein, was mir egal ist. Und wer sich hinter einer Mauer versteckt, ist nicht kalt, der fühlt sich gerade nur nicht sicher. Sharon erklärt, warum Beziehungsfähigkeit keine Charaktereigenschaft ist, die man hat oder nicht hat. Sondern eine Fähigkeit, die man lernen kann. Wie Kommunikation. Wie Empathie. Wie das mutige, verletzliche Gespräch, das alles verändern kann. Du wirst in dieser Folge verstehen, dass die schönste Beziehung nicht die ist, in der alles perfekt läuft. Sondern die, in der beide bereit sind, gemeinsam in dieselbe Richtung zu schauen. Wie auf einem Tandem. Gemeinsam losfahren. Und unterwegs entscheiden, wo es hingeht. +++ Mein neues Buch "Heute hör ich auf zu zweifeln": https://amzn.to/4veLpms Melde dich kostenfrei zum Newsletter an: https://sarahdesai.de/mindful-minute Meine Ausbildung und Kurse findest du hier: https://sarahdesai.de Dr. Sharon Brehm's Webseite: https://lovemoves.de

Diabetes technology is evolving faster than most people realize — and Ken and Graham break down exactly what that means for your day-to-day management. Plus, Ken closes with something every person living with diabetes needs to hear right now.

Ep 273 “The Tactical Tandem Initiative” – National Gun Violence Awareness Month (Bullet Poof Bulletins) Celebrating the launch of eco-fiction anti-gun novella Bullet Poof and National Gun Violence Awareness Month, Avis Kalfsbeek brings back beloved Kitty O'Compost with the Bullet Poof Bulletins. Tonight on the Spoke-Easy stage, Kitty O'Compost breaks down a leaked corporate pitch deck exposing a bizarre cross-marketing partnership between a weapon manufacturer and a lifestyle bicycle brand. This bulletin satirizes the creation of gun-themed bicycle accessories designed for consumers who are forced to ride for health reasons but refuse to leave their defensive aesthetics behind. Inspired by the grounding, collaborative themes of Bullet Poof, this episode laughs at the commercialization of everyday recreation and points us back to the true, uncommodified wellness found in a simple ride around the block. Resources: Bullet Poof is a hopeful eco-fiction novella about what happens when ordinary people refuse to accept the gun status quo. Get the book: https://www.aviskalfsbeek.com/bullet-poof National Gun Violence Awareness Month: www.wearorange.org Theme Music: "Turn the Steel" and punk intros produced by Avis Kalfsbeek (via ElevenLabs). Music Credits & Support: Buy LPs and music downloads directly from the bands' websites, or from platforms like Bandcamp where artists retain the majority of your purchase. This project is inspired by decades of punk ethos, raw energy, and the brilliant musicians who shaped the movement. The sonic landscape of this series was informed and inspired by: The Sex Pistols, Black Flag, Rites of Spring, The Buzzcocks, Minor Threat, The Clash, Social Distortion, Bad Religion, The Dead Kennedys, The Ramones, Jawbreaker, Fugazi, Rise Against, The Damned, The Stooges, Bad Brains, Bikini Kill, The Lawrence Arms, Husker Du, Pennywise, The Adicts, The Exploited, Descendents, Stiff Little Fingers, Crass, The Germs, Dropkick Murphys, Operation Ivy, Against Me!, Green Day, Blink-182, The Hives, Sleater-Kinney, The Violent Femmes, The Network, The Jam, The Gaslight Anthem, No Use For A Name, and The Interrupters.

It's In The News - a look at the top diabetes stories and headlines happening now!   Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Episode transcript: fall Detroit and Seattle.   Okay.. our top story this week: XX The FDA approved Tzield for use in stage 3 T1D – that's what we used to just call type 1. It's the stage where the body can no longer produce enough insulin on its own to manage blood sugars you need to start insulin. This approval is for kids ages 8-17 within 8 weeks of a stage 3 T1D diagnosis. It comes after the PROTECT trial and it's the first approval of a disease-modifying therapy for stage 3 T1D. https://www.prnewswire.com/news-releases/breakthrough-t1d-celebrates-approval-of-tzield-for-use-in-stage-3-type-1-diabetes-in-the-us-302799532.html XX Encouraging results from a small study of islet cell transplantation in people with type 1 where now all 12 participants in the trial are currently living without external insulin after receiving transplanted insulin-producing islet cells.   The study, led by researchers at the University of Chicago, tested an experimental immune therapy called tegoprubart Te-GO-Proo-Bart. The drug is designed to prevent the body from rejecting transplanted cells while avoiding some of the side effects associated with standard anti-rejection medications. You've probably heard about this as the Eledon study – many of the participants have been very active on social media. It was presented at ADA. transplants.https://www.breakthrought1d.org/news-and-updates/tegoprubart-islet-transplant-all-participants-off-external-insulin/ XX New data suggest that acmopatide (ack-MOW-puh-tyd) (CT-868), an experimental once-daily dual GLP-1/GIP receptor agonist, may help people with type 1 diabetes improve blood sugar control, lose weight, and reduce insulin use. Across all doses, participants lost up to 7% of their body weight and reduced insulin use by as much as 15%. The study lasted just 16 weeks, so researchers say longer-term data will be needed to determine whether the benefits can be maintained and whether lower insulin requirements can be achieved without increasing the risk of hypoglycemia. XX A new combination therapy that pairs an amylin analog with semaglutide improved both blood sugar levels and weight loss in several groups of people with type 2 diabetes. The once-weekly injectable, known as CagriSema (KAG-ruh-SEM-uh), was evaluated in three Phase 3 REIMAGINE studies. In people early in the course of type 2 diabetes, researchers reported A1C reductions of up to 1.8 percentage points and significant weight loss compared to placebo after 40 weeks of treatment. Investigators also noted improvements in several cardiometabolic risk factors, including blood pressure. https://www.medpagetoday.com/meetingcoverage/ada/121658 XX Stelo for kids is now FDA cleared.. the over the counter Glucose Biosensor System is now approved for children as young as 2 years old who do not use insulin. The FDA identified pediatric prediabetes as a growing public health concern motivating the expanded indication, noting OTC CGMs can help younger users and their caregivers build glycemic awareness, track patterns in response to me https://www.hcplive.com/view/fda-clears-first-otc-glucose-monitor-for-children XX Insulet presented new data from its STRIVE and EVOLUTION 3 studies showing improved glucose control with its next-generation Omnipod 6. That's , the company's upcoming hybrid closed-loop system for people with type 1 and type 2 diabetes. The main difference between the Omnipod 6 and Insulet's current Omnipod 5 patch pumps is that the new system has a lower glucose target of 100 mg/dL and better Bluetooth connectivity Insulet also shared progress on a fully closed-loop system designed specifically for type 2 diabetes. It  does not require carb-counting or insulin bolusing ahead of meals. Physicians also don't need to program the starting settings.   XX Abbott shared new research highlighting challenges in identifying and managing diabetic ketoacidosis (DKA). The studies coincide with the company's development of Libre Duo, a dual glucose-ketone sensor that continuously tracks both measurements. Abbott reported that DKA can be difficult to recognize when patients first arrive at the hospital, based on data from more than 100,000 people. The company has submitted the dual sensor to the FDA and recently received CE Mark approval in Europe. More news from ADA including info from Dexcom, Sequel, Sensonics and the world loses a tireless T1D advocate.. that's all to come right after this. --   Back to the news.. XX   Dexcom announced its acquisition of Nutrisense, a company that combines continuous glucose monitoring with nutrition coaching and behavioral support. At ADA, the company also presented results from the CONNECT study showing significant A1C reductions and improved glucose control in people with type 2 diabetes not using insulin. The findings add to growing evidence supporting CGM use beyond intensive insulin therapy. We did an episode with CEO Jake Leach at ADA about these announcements as well as updates on G8, their hospital product and much more. XX Sequel Med Tech reported positive clinical results evaluating its twiist automated insulin delivery system in people with type 2 diabetes. The study showed improvements in A1C and time in range over 13 weeks XX Senseonics presented new real-world data supporting the performance of its Eversense 365 implantable CGM. The analysis included more than 12,000 sensors and demonstrated sustained accuracy and effectiveness in both open-loop and automated insulin delivery settings. Researchers also evaluated Eversense use with Sequel Med Tech's twiist system. The findings support broader use of long-term implantable CGM technology.   -- MiniMed used ADA 2026 to spotlight two recently cleared diabetes management systems. The MiniMed Flex pump offers a smaller, smartphone-controlled insulin pump option, while MiniMed Go combines the InPen smart insulin pen with Abbott's Instinct sensor. The products received FDA clearance earlier this year. XX Tandem Diabetes Care highlighted data supporting the use of its Control-IQ automated insulin delivery technology during pregnancy. Results from the CIRCUIT trial showed users spent approximately three additional hours per day in the recommended pregnancy glucose range compared with standard therapy. The findings helped support recent regulatory approvals for pregnancy use in both Europe and the United States. Tandem also expanded indications for adults with type 2 diabetes. XX Beta Bionics presented real-world data from the first three years of iLet Bionic Pancreas use. The company reported a 25% improvement in time in range among users, along with positive feedback from clinicians about simplified diabetes management. The iLet system requires only a user's weight to begin therapy and eliminates carbohydrate counting. Beta Bionics also highlighted growing access to near-real-time outcomes through its public data dashboard. XX MannKind presented new findings supporting its Afrezza inhaled insulin at ADA 2026. A post-hoc analysis of the INHALE-1 study found that pediatric users reported greater treatment satisfaction compared with those using rapid-acting injected insulin. The results come shortly after FDA approval expanded Afrezza's indication to include children. We did a bonus episode with one of the lead investigators of the study that lead to that approval. XX Adaptyx presented early clinical data supporting a wearable sensor that continuously measures cortisol levels. The device successfully tracked cortisol changes during both controlled testing and overnight monitoring in first-in-human studies. Company leaders say cortisol plays a major role in conditions including diabetes, hypertension, and depression. The technology uses synthetic DNA-based molecular switches to generate real-time readings.   XX Biolinq shared new clinical findings for its Shine continuous glucose monitoring system. The needle-free device combines glucose monitoring with activity and sleep tracking .The system received FDA clearance in 2025. They're also looking at measuring lactate through the sensor. XX Long-time T1D advocate Kent Schnakenberg died last week. Schnakenberg was known in his community for using his love of bicycling to raise awareness of Type 1 diabetes. He also advocated for improving the lives of those living with the disease. Inspired by his niece, Michelle, who was diagnosed with juvenile diabetes when she was 13 years old, since 2014 he has traveled around the country cycling thousands of miles, speaking to hundreds and hundreds of kids and raising Money. According to Schnakenberg's family, he suffered a head trauma incident in his home on Wednesday. I spoke to Kent years ago – I believe the first year of the podcast. A sad loss but wonderful to see so many tributes and memories posted on social media in the last few days. https://diabetes-connections.com/john-costik-co-creator-of-nightscout-team-schnak/ https://www.wibw.com/2026/06/12/team-schnak-founder-kent-schnakenberg-passes-away/ XX And finally. Alexander Zverev (ts-ver-uhv) won the French Open, his first Grand Slam title. He lives with type 1, he paused a couple of time to check his blood sugar. He was diagnosed at age 4 and partners with Medtronic. "Becoming a professional tennis player was always my dream," Zverev shared in an article posted by Medtronic. "Early on, I was told that competing at the highest level with diabetes was impossible — but my family and I refused to accept that. That's why I'm partnering with Medtronic Diabetes: I want every person with diabetes to feel empowered to live the life they want." He also has a foundation committed to children with type 1 diabetes. Among other things, the life-saving insulin and other essential drugs are provided – also in developing countries." https://www.mensjournal.com/news/alexander-zverev-diabetes-wins-french-open-2026-medical-condition

Ahead of next week's Royal Highland Show being held at Ingliston just outside Edinburgh, Rachel catches up with farmer Anna Mitchell, who is one of this year's vice presidents. This year's presidential team are representing Aberdeenshire and Anna tells Rachel what visitors can expect from the show.Mark is in Newport-on-Tay with author Dr Erin Farley whose most recent book, Lighthouse Lives, tells the stories of the last generation to work on manned lighthouses across Scotland. She tells Mark about the experiences of some of the keepers and their families who she recorded with for the book.Phil Sime and Morven Livingstone meet Allan MacKinnon of Highland Bird Control Services, to see how he's tackling the issues that gulls are causing at Raigmore Hospital in Inverness.Two volumes of Birds of America by renowned artist and ornithologist John James Audubon are currently on show to the public at the Royal College of Physicians and Surgeons of Glasgow. The College has owned the art treasures for two centuries, and Mark went to meet their heritage lead, Claire McDade to hear a bit about their origins and take a look at the impressive books.Rachel is in Ayrshire meeting some of the farmers involved in the women in dairy initiative.As Scotland fans descend on Boston, Massachusetts in their thousands, we hear about the different birds that the discerning football supporter might be able to spot during their stay in the city. Erin Kelly from conservation charity Mass Audubon tells Rachel a bit about Boston birdlife and where to see it.The Glasgow Tandem Club has members who are both vision impaired and sighted. They are based in Ballahouston Park in Glasgow and Rachel went along to meet some of the members and chatted to founder, Anne Fraser.Mark heads to Cullen to meet the founder of Blue Lighthouse surf club, which was set up to offer tangible support for the health and wellbeing of members of the emergency services and care workers.And in this week's Scotland Outdoors podcast, Mark visits the Taliesin Community Woodland in Dumfries and Galloway which is celebrating its 30th anniversary. We hear an excerpt.

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, compagni di avventura!

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, compagni di avventura!

Marco Dané "Se potessimo fare un bel gioco"Dal Paese di Giocagiò a Tandem. La tv dei ragazzi raccontata da uno dei suoi protagonisti.Manni Editoriwww.mannieditori.itLa televisione per bambini era diventata il mio mondo. E per molti bambini, quella televisione è stata una finestra sul possibile. Abbiamo parlato con loro, non solo per loro. Abbiamo giocato, raccontato, cantato, spiegato, ma abbiamo anche ascoltato. E quando oggi un adulto mi ferma per strada e mi dice: «Io ti guardavo da piccolo, mi hai insegnato a sorridere», sorrido anch'io. Perché so che in quel viaggio, io non ero solo. Eravamo in tanti. E tutti abbiamo imparato qualcosa. Marco Dané è stato un protagonista dei programmi televisivi per ragazzi come autore e conduttore: dall'esordio nel 1969 nel Paese di Giocagiò al fianco di Gianni Rodari, a Trentaminutigiovani, il tg per ragazzi di Rai2, a Tandem negli anni Ottanta con Fabrizio Frizzi, fino al ruolo di giudice in Paroliamo (quello in Rai e poi all'interno di Non è la Rai di Gianni Boncompagni), ha contribuito alla nascita di un'epoca d'oro della televisione italiana, in cui l'intento educativo sapeva coniugarsi con l'intrattenimento intelligente.In queste pagine Dané ripercorre le sue trasmissioni che hanno segnato intere generazioni, restituendo la magia dei personaggi come Signor Coso, Scarabocchio, Buendìa, il Pagliaccio... È un viaggio nella storia della tv per ragazzi e una scoperta delle prime sperimentazioni tecniche, come l'evoluzione dei mezzi di ripresa, l'elettronica, le nuove possibilità di interazione con i telespettatori.Per gli adulti di oggi, questo libro è un ponte con l'infanzia: una galleria di ricordi, emozioni e nostalgia ma anche la dimostrazione di come la fantasia, il gioco e l'intrattenimento possano essere una cosa seria.Diventa un supporter di questo podcast: https://www.spreaker.com/podcast/il-posto-delle-parole--1487855/support.IL POSTO DELLE PAROLEascoltare fa pensarehttps://ilpostodelleparole.it/

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, compagni di avventura!

www.floridacpabookkeeping.comwww.insurancebrokerplus.comwww.strategicconsultingexperts.ccom

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, compagni di avventura!

It's in the News! The top diabetes stories and headlines happening now. Top stories this week include: Afrezza inhaled Insulin is Approved for Kids, CGM + Ketone Monitor gets European approval, Food Coloring & Diabetes Study, Device Recalls include Omnipod and Dexcom, Beta Bionics shares more about their patch pump, ADA conference info and more! This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Episode transcripts: Welcome! I'm your host Stacey Simms and this is an In The News episode.. where we bring you the top diabetes stories and headlines happening now. A reminder that you can find the sources and links and a transcript and more info for every story mentioned here in the show notes. ADA starts this week – safe travels to those of you heading to New Orleans. We'll be covering remotely so please follow on social – make sure to Like the FB page or join the group. We've got a wrap up episode planned for this podcast as well as some indepth interviews with the newsmakers from the conference. I will see some of you next week in Chicago. We have a couple of seats left for our Club 1921 dinner on June 10th in Northbrook – this is a FREE dinner for HCPs and patient leaders – all about screening for T1D. More info on the website under the events tab. Okay.. our top story this week: XX Afrezza inhaled insulin is now approved for kids and teens. The FDA okayed MannKind's afrezza for children 6 and older with type 1 and type 2 diabetes. MannKind says its proprietary Technosphere drug delivery platform enables the rapid absorption of insulin into systemic circulation. This follows FDA approval earlier this year for an update that revises recommendations for the starting mealtime dosage when patients switch from subcutaneous mealtime insulin regimens. MannKind also completed enrollment in February for a study evaluating the initiation of Afrezza therapy shortly after type 1 diabetes diagnosis in pediatric patients.   The company said it made Afrezza available for eligible patients for $35 or less per month. Desmond Schatz, professor of pediatrics at the University of Florida College of Medicine, said: "Mealtime insulin can be especially challenging for children because eating and snacking patterns, activity levels, and daily settings like school and sports often vary. With its rapid onset and dosing at the start of a meal, Afrezza may help clinicians better match insulin therapy to how children and families live day to day, while offering a needle-free mealtime option." Lots more to come on this – we're working on a bonus episode with one of the pediatric endos who worked on the clinical trials that led to this approval – hopefully have that out later this week. https://www.massdevice.com/mannkind-fda-approval-inhaled-insulin-children/ XX FDA has agreed to consider a new drug for the treatment of adults with type 1 and chronic kidney disease. Finerenone (fy-near-uh-known) is currently approved in the US for adults with CKD associated with type 2 diabetes and for adults with heart failure with left ventricular ejection fraction of 40% or greater. Chronic kidney disease (CKD) is present in over one-third of adults with diabetes, and because it's such a serious condition, interventions are needed to reduce its incidence and help people live a long and prosperous life. https://www.docwirenews.com/post/fda-grants-priority-review-to-finerenone-snda-for-type-1-diabetes-associated-ckd XX Abbot gets European approval for the world's first dual glucose‑ketone sensing technology for people with diabetes. They're calling this Libre Duo and Libre Duo 10 Day, and it's designed to continuously measure glucose and ketone levels every minute. Abbott plans to begin launching Libre Duo systems in select European countries later this year. Libre Duo delivers up to 15 days of wear and will be offered to adults ages 18 and older. Libre Duo 10 Day offers up to 10 days of wear and is intended for people ages 2 and older. Abbott is also working with leading pump companies to allow automated insulin delivery (AID) systems to connect with the sensors. https://abbott.mediaroom.com/2026-05-27-Abbott-secures-CE-Mark-for-worlds-first-dual-glucose-ketone-sensing-technology-for-people-with-diabetes   XX Huge recall for Omnipod. Insulin says a manufacturing issue through ongoing product monitoring that could result in insulin under-delivery  with specific lots of its Omnipod 5, Dash and Eros pods. Insulet said the scope of this action reaches approximately 7 million pods. This issue is separate from the March recall that affected certain Omnipod 5 lots. According to the Acton, Massachusetts-based company, some of its affected pods may have a small tear in the tubing (cannula) just above the skin. This tear lands between the pod and the point where the cannula enters the body. If this occurs, insulin may leak outside of the device instead of being fully delivered into the body as intended. This may lead to under-delivery of the therapeutic.   Individuals using an affected pod may notice wetness on the skin or pod adhesive or detect the smell of insulin. However, some cases may prove difficult to detect and go unnoticed. Of the approximately 7 million pods included in the action, approximately 60% have been consumed or are expired. The pods affected by the correction represent approximately 8.5% of the 2025 global Omnipod pod prodcution. Insulet says it has sufficient supply to replace affected pods. It expects no disruption to product availability. The company said it has notified the FDA and all other relevant regulatory authorities of its action.   The full list of affected pod lots can be found here. https://www.massdevice.com/insulet-another-omnipod-5-recall-dash-eros/ XX Dexcom is warning that certain scrapped glucose sensors have been stolen and resold. Dexcom said it has not received any reports of severe adverse events associated with the stolen product. One lot of scrapped devices carries a risk of infection for sensors that are not properly sterilized, and another lot had an elevated internal testing failure rate, meaning users would have an increased risk of having no sensor readings available. Dexcom said the affected sensors were stolen during the destruction process and then sold by third parties. The company routinely scraps sensors that do not meet its standards. The sensors are sent to a third-party vendor for destruction and recycling.   Dexcom said it traced sales of the stolen devices to Pharmsource, which is not an authorized Dexcom distributor but supplies some independent pharmacies and U.S. durable medical equipment distributors. Because of this, pharmacies that purchase products from Pharmsource should review their inventory, Dexcom said.   People with sensors from the affected lots should not use those sensors and can call customer support to request replacements. Dexcom has set up a website to help users check if their devices are affected. https://www.medtechdive.com/news/dexcom-warns-of-scrapped-glucose-sensors-being-resold/821139/ XX XX   Beta Bionics plans to debut its first insulin patch pump by the end of the second quarter of 2027, subject to Food and Drug Administration clearance. The device, called Mint, would be compatible with Beta Bionics' interoperable automated glycemic controller, a software that allows for the pump to automatically adjust insulin delivery based on readings from a glucose sensor. Beta Bionics first unveiled the prototype for Mint last year at the American Diabetes Association's Scientific Sessions. The device is expected to have a similar size and wear time, at three days, to Insulet's patch pumps on the market. It would have a 200-unit insulin reservoir.   Mint differs by containing a mix of reusable and disposable components. Beta Bionics plans to make the device exclusively available in the pharmacy channel, building on its existing agreements for its current iLet insulin pump. Beta Bionics is one of several diabetes tech companies developing patch pumps to compete with market leader Insulet. Tandem Diabetes Care and Medtronic spinoff MiniMed have also announced planned patch pumps. Tandem said it plans to file a 510(k) submission this quarter for a tubeless version of its small, durable pump, and Medtronic plans to submit its patch pump to the FDA this fall.   https://www.medtechdive.com/news/beta-bionics-to-launch-its-first-insulin-patch-pump-to-compete-with-insulet/821091/ XX CVS puts Zepbound back on it's coverage list – with it's Caremark PBM. They also added Foundayo, Lilly's obesity pill. CVS had dropped Lilly's Zepound last summer but kept competitor Wegovy. It'll be back at Caremark October first. All three of the nation's largest pharmacy ⁠benefit managers ​now cover Lilly's full obesity medicine portfolio. https://www.reuters.com/legal/litigation/cvs-brings-back-coverage-lillys-obesity-drug-zepbound-2026-05-28/   More to come, including a new benefit from metformin for women, something new from Tidepool, big news for T1D in Austalia and more.. XX A new study suggests that higher long-term exposure to food colouring additives — including both synthetic and natural colourings commonly found in processed foods and beverages — may be associated with an increased risk of developing type 2 diabetes. Researchers analyzed data from more than 108,000 adults in the French NutriNet-Santé cohort between 2009 and 2023, following participants for a median of just over eight years. During that time, 1,131 participants developed type 2 diabetes. The study found that people with the highest intake of total food colouring additives had a 38% higher risk of developing type 2 diabetes compared with non- or low-consumers.   Several specific additives were linked to increased risk, including caramel colouring additives such as total caramel (E150 family), plain caramel (E150a), sulphite ammonia caramel (E150d), and beta-carotene (E160a). Additional associations were observed for curcumin (E100), anthocyanins (E163), paprika extract (E160c), lutein (E161b), and cochineal-derived colourings (E120). "Our findings revealed positive associations between widely consumed food colouring additives and type 2 diabetes incidence," the authors wrote, adding that further research is needed to better understand the mechanisms behind the findings and whether food colouring regulations should be reevaluated. https://www.medscape.com/viewarticle/use-common-food-colours-tied-high-type-2-diabetes-risk-2026a1000hes XX Big news for Australia – their Therapeutic Goods Administration (TGA) approves Tzield. Tzield is now approved in Australia to delay the onset of stage 3 (or clinical) T1D in people aged eight years and older with stage 2 T1D – the early, pre-symptomatic stage of the condition, where changes in blood glucose levels have begun but insulin therapy is not yet required. Breakthrough T1D Australia Chief Executive Officer, Sydney Yovic, said the approval represented a transformational moment for Australians affected by T1D. https://newshub.medianet.com.au/2026/05/landmark-approval-of-tzield-in-australia-ushers-in-a-new-era-of-delay-for-type-1-diabetes/155036/ XX https://www.theatlantic.com/health/2026/05/diabetes-pregnancy/687324/ XX A common diabetes drug may hold great potential to help with aging, even if scientists aren't exactly sure why. According to a study, the drug metformin doesn't just help patients to effectively manage their type 2 diabetes. it may also give older women a better chance of living to 90. Scientists in the US and Germany used data from a long-term US study of postmenopausal women.   Records for a total of 438 people were selected – half of whom took metformin to treat diabetes, and half of whom took a different diabetes drug, sulfonylurea.   While there are some caveats and asterisks to the study, those in the metformin group were calculated to have a 30 percent lower risk of dying before the age of 90 than those in the sulfonylurea group. The study used age 90 as the marker for 'exceptional' longevity. However, scientists aren't yet sure that the drug extends lifespan, especially in humans – which is part of the reason for this study. RCTs could follow further down the line to dig deeper into these results, the researchers suggest. In the meantime, as the global population continues to skew older, studies continue to find ways to keep us healthier for longer and reduce damage to the body as we age. https://www.sciencealert.com/a-common-diabetes-drug-is-linked-with-exceptional-longevity-in-women XX The American Diabetes Association® (ADA) will host the 2026 Scientific Sessions from June 5-8 in New Orleans. The ADA's Scientific Sessions is the world's largest diabetes meeting, convening an expected audience of over 12,000 leading physicians, scientists, researchers, and healthcare professionals from around the globe. The premier diabetes meeting, which is also offered virtually, will feature the latest scientific findings in diabetes and obesity, where leading experts and peers will share findings in research for prevention, care, and cures at the Ernest N. Morial Convention Center. Key themes will include: Advancing obesity and metabolic health: Prevention, early detection, and disease modification: Improving cardiometabolic outcomes: Transforming care through innovation and access: New research will highlight how technology, artificial intelligence, and implementation strategies are reshaping diabetes care—reducing treatment burden, expanding access, and enabling more person-centered care. Advancing beta cell replacement and cure strategies: Fostering innovation: On Saturday, June 6, from 4:30-6:00 p.m., the Innovation Challenge, which debuted in 2023, invites emerging companies to pitch novel ideas to improve the lives of people living with diabetes. A panel of judges, with input from a live audience, determines which contestants will earn a private audience with potential funders. XX Tidepool, the nonprofit leader advancing innovation in diabetes technology, announced that Tidepool+ Direct Connect is now available through the Epic Showroom. Built on SMART on FHIR, Direct Connect brings interactive diabetes device data directly into Epic workflows, helping clinicians use patient data during routine care. "Tidepool has always focused on making diabetes data more accessible and actionable," said Brandon Arbiter, CEO. "We're excited to empower clinicians using Epic with insightful, intuitive patient data that fits directly into their encounter workflow so they can use it to improve care in the moment it matters."   Tidepool+ Direct Connect supports scalable deployment across Epic-enabled health systems. This architecture enables faster, more intuitive rollouts, enhancing Tidepool's existing EHR integration capabilities.   Direct Connect is part of Tidepool's ongoing work to improve how clinicians can use timely and relevant diabetes device data during patient visits to help drive better health outcomes.   The feature is now available in the Connection Hub of the Epic Showroom.   https://www.businesswire.com/news/home/20260527780274/en/Tidepool-Launches-in-Epic-Showroom-to-Bring-Diabetes-Device-Data-into-the-Point-of-Care XX

Tandem's Investment Team is back with Episode 24 of Tandem Talk. Since February, markets have kept marching to the beat of one drum: AI. The team draws on historical parallels, digs into what the portfolio's fundamentals are actually doing, and asks why the companies that survive a capital expenditure boom are rarely the ones the market bets on early.

Spin-off de Total il y a vingt ans, Arkema est devenu un champion français dans un contexte difficile. Dans « La Story », le podcast d'actualité des « Echos », Clara Grouzis et Nicolas Rauline reviennent sur l'histoire de l'entreprise.« La Story » est un podcast des « Echos » présenté par Clara Grouzis. Cet épisode a été enregistré en mai 2026. Rédaction en chef : Clémence Lemaistre. Invité : Nicolas Rauline (chef adjoint du service entreprises des « Echos »). Réalisation : Willy Ganne. Chargée de production et d'édition : Clara Grouzis. Musique : Théo Boulenger. Identité graphique : Upian. Photo : Shutterstock. Sons : Arkema Première Ligue, BFM, Les Echos, Sader, Chaîne Youtube « Grâce à la chimie », extrait du film « Tandem ».Retrouvez l'essentiel de l'actualité économique grâce à notre offre d'abonnement Access : abonnement.lesechos.fr Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

Silicon solar is approaching a hard physical efficiency ceiling at 30%. Perovskite tandem solar is the only proven path through it. Joel Jean, CEO of Swift Solar, explains the technology, what the Meyer Burger acquisition brings, and where tandems sit on the road to commercial scale.After seven decades, silicon solar is closing in on its physical efficiency limit, and no previous thin-film technology has been able to outperform it at competitive cost. Joel Jean, CEO and co-founder of Swift Solar, a tandem PV manufacturer based in California, joined Tim Montague on the Clean Power Hour to explain why perovskite-silicon tandems are different and how Swift is building toward commercial scale. Jean explains how Swift's approach of vertically integrating perovskite and silicon at the cell level differs from other tandem strategies, and what certifications and milestones a new module technology must clear before utility buyers and independent engineers will finance it. The conversation also covers the US position in the global solar race, perovskite degradation and lead-content concerns, and what a consistent industrial policy would mean for US solar manufacturers.Here is what you will learn in this conversation about perovskite tandem solar and the path to next-generation module efficiency:You'll understand why silicon solar cells are physically limited to around 30% efficiency, and how stacking a perovskite layer on silicon creates a two-junction cell with a path to 35-40%, with three junctions pushing toward 45% or more.Find out what Swift Solar gains from the Meyer Burger acquisition: a heterojunction product with 0.2% annual degradation, the lowest rate in the industry, and a bankable product to serve customers while the tandem completes its certification and field-proof timeline.Learn why Swift's approach of integrating perovskite and silicon at the cell level differs from other tandem strategies, including four-terminal approaches where perovskite is deposited on glass and stacked on a separate module.You'll hear Tim push back on two common concerns about perovskites: degradation and lead content. Joel explains Swift's cell-level stability progress and why perovskite panels contain less lead per square meter than the solder in a standard silicon module.With China installing solar 8.5 times faster than the US and having spent 15-20 years building a manufacturing and policy foundation, the US is still trying to rebuild. The window for US tandem solar companies to establish a position is narrowing. Swift Solar's acquisition of Meyer Burger assets is one of the few cases where a US perovskite tandem startup enters the market with a proven, bankable product already generating field data, rather than waiting years for the tandem to reach certification. For solar professionals evaluating next-generation module technology and investors tracking the US manufacturing pipeline, this conversation gives a clear picture of where tandem technology stands today and what the next two to three years need to deliver.Connect with Joel Jean, Swift Solar LinkedIn: https://www.linkedin.com/in/joeljean/Swift Solar: https://www.swiftsolar.com/ Support the showConnect with Tim  Clean Power Hour  Clean Power Hour on YouTubeTim on TwitterTim on LinkedIn Email tim@cleanpowerhour.com Review Clean Power Hour on Apple PodcastsThe Clean Power Hour is produced by the Clean Power Consulting Group and created by Tim Montague. Contact us by email:  CleanPowerHour@gmail.comCorporate sponsors who share our mission to speed the energy transition are invited to check out https://www.cleanpowerhour.com/support/The Clean Power Hour is brought to you by CPS America, maker of North America's number one 3-phase string inverter, with over 6GW shipped in the US. With a focus on commercial and utility-scale solar and energy storage, the company partners with customers to provide unparalleled performance and service. The CPS America product lineup includes 3-phase string inverters from 25kW to 275kW, exceptional data communication and controls, and energy storage solutions designed for seamless integration with CPS America systems.  Learn more at www.chintpowersystems.com

Want to live a better balanced life and win in marriage AND business at the same time? Purchase our (audio) book Tandem: The married entrepreneurs' guide for greater work-life balance. https://www.thetandembook.com/ Download the 5 Daily Habits to Thrive in Tandem https://marriedentrepreneur.co/5-daily-habits-download  Need some insight into how to balance it all? Schedule a free discovery call. https://marriedentrepreneur.co/lets-talk In this milestone 250th episode of Thriving in Tandem, Robert and Kay Lee Fukui pull back the curtain on one of the biggest transitions of their marriage and business journey: leaving California and relocating across the country to the Lake Norman area outside of Charlotte, North Carolina. As they record from Dallas during their cross-country road trip, they share the emotions, uncertainty, and real-time stress of making a life-changing move while still trying to protect their marriage, peace, and vision. This episode dives into the reality of "moving without a plan"—not because they lacked vision, but because many details were still unfolding in real time. Robert and Kay Lee discuss how a shared long-term vision helped them navigate one of life's greatest stressors without turning against each other. They unpack the importance of testing major decisions over time, communicating honestly during stressful moments, creating backup plans, and refusing to let uncertainty create division in their marriage. For married entrepreneurs, this conversation is a powerful reminder that growth often requires discomfort. Whether you're making a major move, navigating business uncertainty, or stepping into a new season of life, success isn't about having every detail perfectly figured out. It's about staying united, keeping your peace, and moving forward together even when the path ahead isn't fully clear. Key Takeaways Celebrating the milestone of 250 podcast episodes while entering a major life transition Why having a shared vision is critical during stressful seasons of marriage and business How testing major life decisions over time can strengthen confidence and unity The emotional and practical realities of uprooting your life and moving across the country How stress can either divide a couple or make them stronger together Why moving forward imperfectly is often better than waiting for the "perfect plan" The importance of protecting your peace and supporting your spouse during uncertainty

This week, we kick off SEASON 27 with our favorite sentient gasbag, Steven Seagal. Attack Force came out at the height of his direct-to-video downfall, and boy does this one stink! Who would have thought that the guy who brought us On Deadly Ground could fall so far from grace. Wshhhshhshhhshh!!!Seagal, supple and sauntering, unsubtly switches speak, swinging sharp slicers, sucking up scenery, unsexily secreting salty sweat! Leathered Matrix men! Military hardware highjacking! Steven Sheen! Damn, he's so good! Green marines splitting the scene! Foggy gumbo bags! Tandem hole jams! The ole stripper puke exclusion! Marshall Martin meets his makeout mistress at the midtown mocha market! Reina, the vampire stripper? Pimp and his blood-sucking CTX hoes, and much, much more on this week's episode of The Worst Movie Ever Made! www.theworstmovieevermade.com

In this episode, Phil Schiller and Erik Dondzila share their entertaining experience racing Iceman Cometh Challenge on a tandem - and Dan Frayer from West Michigan Mountain Bike Alliance explains how the Yankee Springs Time Trial helps contribute annually to the West Michigan mountain bike trail system.

Send us Fan MailSometimes the biggest adventures begin after life falls apart.This week on Here's What We Know, our host, Gary Scott Thomas, sits down with author Teri M Brown about surviving emotional abuse, rebuilding self-worth, and riding a tandem bicycle across America with her husband.Their 3,102-mile journey became more than a cycling trip. It became a story about resilience, relationships, fear, kindness, and discovering what's possible when you stop letting your past define you.This conversation is funny, vulnerable, deeply human, and exactly the kind of unexpected story that reminds us how powerful connection can be.Listen now and discover why Teri says adventure can restore your faith in humanity.In This Episode:How Teri rebuilt confidence after emotional abuseWhat riding across America taught her about resilienceWhy tandem bicycles are called “divorce machines”What cross-country travel revealed about humanityHow adventure changes relationships and identityWhy most people are far kinder than the internet makes us believeThis episode is sponsored by:Dignity MemorialBio:Born in Athens, Greece as an Air Force brat, Teri M Brown graduated from UNC Greensboro. She began her writing career helping small businesses with content creation and published five nonfiction self-help books dealing with real estate and finance, receiving multiple awards.In 2017, after winning the First Annual Anita Bloom Ornoff Award for Inspirational Short Story, she began writing fiction in earnest, and published her debut novel in 2022, Sunflowers Beneath the Snow, a historical fiction set in Ukraine. Her second novel published in 2023, An Enemy Like Me, takes place during WWII. Her third novel, Daughters of Green Mountain Gap, a generational story about Appalachian healers came out in January 2024. 10 Little Rules for a Double-Butted Adventure (Feb 2025), is an inspirational look at the life lessons she learned riding across the United States on a tandem bicycle. Little Lola and Her Big Dream, is a children's picture book helping children realize that it is okay to have big dreams even in the face of opposition. Her newest work, Peg, Unhinged (April 2026), is a humorous contemporary women's fiction looking at menopause.​Teri is a wife, mother, grandmother, and author who loves word games, reading, bumming on the beach, taking photos, singing in the shower, hunting for bargains, ballroom dancing, playing bridge, and mentoring others.https://www.terimbrown.com/Tags: tandem bicycle across America, emotional abuse recovery, resilience stories, cross-country bicycle trip, adventure podcast, inspirational life stories, healing after trauma, tandem bike journey, overcoming fear, personal growth podcast, cycling across America, relationship stories, life after divorce, podcast interviews, human connection stories, emotional resilience, storytelling podcast, author,Connect with Gary:Gary's WebsiteFollow Gary on InstagramGary's TiktokGary's FacebookWatch the episodes on YouTubeAdvertise on the PodcastThank you for listening. Let us know what you think about this episode. Leave us a review!

It's In The News - where we bring you the top diabetes stories and headlines happening now. This week, Tzield approved down to age one and over, Omnipod trials for fully closed loop, Tandem approved for pregnancy, Eversense 365 launches in Europe, generic Ozempic in Canada, an award for the T1D Barbie and more.  Announcing Community Commericals! Learn how to get your message on the show here. Don't miss our in-person events: www.diabetes-connections.com/events  Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Okay.. our top story this week: XX The U.S. Food and Drug Administration (FDA) approved Tzield (teplizumab-mzwv) for use in children in stage 2 type 1 diabetes (T1D) ages one and older. The approval expands the previous indication from those aged eight and above and was granted under a priority review process. This decision is supported by one-year data from the PETITE-T1D Phase IV study, which evaluated the safety and pharmacokinetics of Tzield in children under eight years old. Tzield was approved for use in individuals 8+ in stage 2 T1D in 2022. Since then, we have been working to expand the eligible population. This expansion effort includes individuals in stage 3 T1D, who can preserve endogenous insulin production for longer when they take Tzield and, most notably today, children in stage 2. https://www.breakthrought1d.org/news-and-updates/tzield-approved-for-children-ages-one-and-older-in-stage-2-t1d/   XX Big write up in the journal Pediatrics about screening for type 1. Citing the 2025 ADA Standards of Care in Diabetes, the opinion piece talks about how to engage the greater healthcare community.  It says: We aim to encourage the development of strategies to emphasize the importance of T1D early detection, integrate screening into routine health care encounters, and support implementation of T1D screening. Pediatricians and other primary care clinicians are well positioned for greater collaboration with the multidisciplinary team, ensuring early detection, timely intervention, and improved outcomes. https://publications.aap.org/pediatricsopenscience/article/2/2/1/207272/Type-1-Diabetes-Screening-in-Pediatrics-Putting?autologincheck=redirected   XX More info about GLP-1 drugs and people with type 1. New study shows off label use did not lead to DKA or pancreatitis in a large 1-year single-center study. Moreover, GLP-1 agonist use in people with T1D was associated with lower overall rates of hospitalization, as has occurred in type 2 diabetes Although GLP-1 agonists are not approved by the FDA for T1D management, off-label adjunctive use has risen for those with obesity. Semaglutide was the most commonly-used GLP-1 (65.5% of GLP-1 users) followed by tirzepatide (23.5%). The rest were using the older-generation drugs: liraglutide or dulaglutide. Lots more information to come on type 1 and glp 1-s in upcoming studies. https://www.medscape.com/viewarticle/use-glp-1s-type-1-diabetes-not-linked-increased-dka-2026a1000d56 XX Health Canada ‌​has approved the first generic ​version of ​Danish ⁠drugmaker ⁠Novo ‌Nordisk's Ozempic drug. In January 2026, the Canadian patent for Ozempic will expire, paving the way for cheap generic versions of the semaglutide injections that help regulate blood sugar levels and appetite. Health Canada said this generic, like existing products, is indicated to be used for the "once-weekly treatment of adult patients with Type 2 diabetes to manage blood sugar levels." With three generics on the market, Tadrous said the price could drop to about $100 or less, depending on their dose. Health Canada said it's currently reviewing eight other generic submissions by different companies and expects to make a decision on these in the next few weeks and months. https://www.cbc.ca/news/health/ozempic-generic-health-canada-9.7180566 XX  Insulet has enrolled the first participant in a pivotal study for its fully closed-loop (FCL)A automated insulin delivery (AID) system for type 2 diabetes (T2D  The participants are between 18 – 75 years of age, living with T2D and using insulin (basal-bolus or basal-only). The Company received Investigational Device Exemption (IDE) approval in March 2026 from the U.S. Food and Drug Administration (FDA). The Company plans to submit a 510(k) filing to the FDA in 2027 and launch its FCL AID system for T2D in 2028.   XX insulet Corporation (PODD) has initiated a voluntary recall of certain lots of its Omnipod 5 insulin delivery Pods in the U.S. after detecting that some devices had a manufacturing defect that causes insulin leakage.   Patients using the affected devices could risk experiencing high blood glucose levels due to insufficient insulin delivery, the Acton, Massachusetts-based MedTech disclosed in a statement late Thursday. The company has already notified the FDA about the recall, which it said will affect nearly 1.5% of Omnipod 5 pod units it manufactures annually. The customers were advised to immediately seek a product replacement at no cost if a Pod from a defective lot is currently in use. https://www.msn.com/en-us/money/companies/insulet-recalling-certain-defective-omnipod-insulin-delivery-devices/ar-AA1YyslT?apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1&bundles=feat-es2020-c XX Tandem Diabetes Care (Nasdaq:TNDM) gets FDA clearance for its automated insulin delivery (AID) technology for use in pregnancy. The FDA cleared the company's Control-IQ AID technology for use in what they call: pregnancy complicated by type 1 diabetes mellitus. Tandem says t:slim X2 and Mobi are the first and only commercially available AID systems cleared for use during pregnancy in the U.S. https://www.drugdeliverybusiness.com/tandem-fda-clearance-aid-pregnancy-t1d/ XX Tandem also issued an urgent medical device correction for a software problem with its Mobi insulin pumps. The malfunction may cause insulin delivery to stop, causing high blood sugar if not addressed, the Food and Drug Administration said in a Wednesday recall notice. We told you about this back in October when Tandem sent a letter to customers notifying them of the fault and instructing them to update their pump software as soon as possible. The FDA now issued a class one recall, the most serious type. We just released a bonus episode all about Tanem – tubeless mobi and what else is in the pipeline. You can listen to that wherever you are listening to this.. it's the episode just before this one. https://www.medtechdive.com/news/tandem-recalls-mobi-insulin-pumps-over-software-malfunction/818260/   XX Switching CGMs didn't make a measurable difference for adults using MiniMed's pump system. In a real-world analysis presented at the International Conference on Advanced Technologies & Treatments for Diabetes, researchers found that CGM metrics for patients who switched from the Guardian 4 sensor (MiniMed) to Instinct by Abbott were able to maintain a time in range of greater than 75%. "When it comes to the automated insulin delivery system ... I think the sensor matters less and the system matters more," Viral N. Shah, MD, professor of medicine in the division of endocrinology and metabolism and director of diabetes clinical research at Indiana University Center for Diabetes and Metabolic Diseases, said during a presentation. "Having a different sensor with the system, I think the [glycemic] outcomes will still be what you want." I'm including this because the headline here seemed to indicate no CGM makes a difference, but this study only looked at two. https://www.healio.com/news/endocrinology/20260401/switching-cgm-sensors-does-not-impact-glycemic-outcomes-with-automated-insulin-delivery   XX Vitamin D supplementation may help delay or prevent disease progression in people with prediabetes.. in people who have specific variants in their vitamin D receptor gene. This was found after a second look at large study where researchers found vitamin d really did make a difference.. a second look with people who had a specific gene variation had much better results. "More research is needed to see if there are other factors that are associated with risk reduction." https://www.medicalnewstoday.com/articles/vitamin-d-supplements-help-prevent-type-2-diabetes-right-gene-variants   XX Senseonics (Nasdaq:SENS) announced today that it initiated the first European launch of its Eversense 365 continuous glucose monitor (CGM). The launch comes a few months after the company picked up CE mark for the long-term, implantable CGM in January. Eversense 365 is the world's first 365-day CGM system. It also holds clearance as an integrated CGM (iCGM) system, meaning it can work with compatible medical devices. Those include insulin pumps as part of automated insulin delivery systems, like the Sequel Med Tech twiist system. The company said it made Eversense 365 available to the first patients in Sweden. It plans to bring the sensor to Germany, Spain and Italy in the coming weeks https://www.drugdeliverybusiness.com/senseonics-launches-eversense-365-europe/ XX A machine learning model can improve genetic prediction of type 1 diabetes by as much as 10%, show results from a University of California, San Diego study.   The researchers used the machine‑learning model T1GRS to improve on a gold standard polygenic genetic risk score used to predict who is likely to develop the condition called GRS2. The GRS2 polygenic risk score has been widely tested and can be used to predict newborns who are at high risk of developing type 1 diabetes. While early prediction can't necessarily stop the disease it can help to prevent emergencies like diabetic ketoacidosis at diagnosis, allow families time to prepare and could allow use of therapies to delay onset of the condition. In this study, Gaulton and colleagues carried out a genome‑wide association study in 20,355 people with type 1 diabetes and 797,363 non‑diabetic Europeans, as well as a further analysis around the MHC region in 10,107 diabetic and 19,639 nondiabetic individuals. https://www.insideprecisionmedicine.com/topics/molecular-dx/machine-learning-tool-helps-improve-type-1-diabetes-prediction/ XX Sen. Mark Warner (D-Va.) said Monday that he will return to the upper chamber this week after taking time off for the death of his daughter, Madison.   The Virginia senator wrote on the social platform X, "As we remember our incredible daughter, Maddy, my family has been deeply touched by the outpouring of support we've received. Thank you to everyone for your kind words." Madison Warner, 36, died earlier this month after a decades-long battle with juvenile diabetes and other health issues. Mark Warner and his wife, Lisa Collis, wrote in a statement last Monday that they were "heartbroken beyond words" by their daughter's passing.   On Monday, the former Virginia governor said his daughter "was a deeply empathetic and engaged person" and that "as recently as the day she passed, she was full of ideas and suggestions" for him, including how he could improve his social media presence.   "She used to say to me: 'Dad, you have the power — you have to use it.' She pushed me to make the most of my position, to use my seat in the Senate to help people in meaningful ways," he added.       "If I can find any solace during this time, it's that I have the enormous privilege to serve Virginians and the responsibility to keep working for a better, more just world in Maddy's name."   Warner concluded, "I look forward to returning to the Senate this week and continuing that essential work."   Madison Warner is survived by two younger sisters.     An estimated than 2.1 million Americans, including about 314,000 children and adolescents younger than age 20, have diagnosed type 1 diabetes as of March — which is what juvenile diabetes is commonly called — according to the CDC's National Diabetes Statistics Report.   An estimated 11 million U.S. adults have undiagnosed diabetes, the report notes.   Symptoms of type 1 diabetes include feeling more thirsty than usual, urinating a lot, bed-wetting in children who have never done so, feeling very hungry and losing weight without trying, according to the Mayo Clinic. https://thehill.com/homenews/senate/5851605-mark-warner-diabetes-death/ XX Mattel, Inc. and Breakthrough T1D just won a Gold Halo Award for Best Cause Product Initiative for the launch of the first Barbie with T1D.  The Halo Awards recognize the most outstanding corporate social impact efforts over the past year.

This week on Diabetes Connections.. an update from Tandem Diabetes. Quite a few approvals and advances have already happened for Tandem this year, as the company looks ahead to the launch of their latest product, the Mobi Tubeless, not yet FDA approved. I'm talking to Marisa Fienup VP of Product Management about how this product is different from the original Mobi, the incorporation of the approved 7-day infusion set, asking your questions and more. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com 

This week: Gates and Sam are caught on camera doing it all over the hospital, Neela faces the harsh reality of her job, Brenner continues to be an absolute (insert expletive of choice here), Abby interviews for a new job at a very fancy clinic, and Lizzie is amazed when the show actually does a decent (but not great) job handling a transgender patient.

What does a design strategist, a former Studio McGee ops director, and a single mom entrepreneur all have in common? They're all Renee Bush, and she joined Mark for one of the most layered conversations the podcast has ever had. Mark and Renee dig into the strategy behind branding, why consistency builds trust faster than talent alone, and what it actually looks like to stop being the bottleneck in your own business. Fair warning: this one will make you want to redesign your entire client experience before the episode is even over. Support the show - https://www.curiousbuilderpodcast.com/shop See our upcoming live events - https://www.curiousbuilderpodcast.com/events The host of the Curious Builder Podcast is Mark D. Williams, the founder of Mark D. Williams Custom Homes Inc. They are an award-winning Twin Cities-based home builder, creating quality custom homes and remodels — one-of-a-kind dream homes of all styles and scopes. Whether you're looking to reimagine your current space or start fresh with a new construction, we build homes that reflect how you live your everyday life. Sponsors for the Episode:  Pella Website: https://www.pella.com/ppc/professionals/why-wood/  Contractor Coalition Summit: Website: https://www.contractorscoalitionsummit.com/ Where to find the Guest:  Website: https://with-tandem.com/ Instagram: https://www.instagram.com/with_tandem/ Where to find the Host:  Website - https://www.mdwilliamshomes.com/  Podcast Website - https://www.curiousbuilderpodcast.com Instagram - https://www.instagram.com/markdwilliams_customhomes/  Facebook - https://www.facebook.com/MarkDWilliamsCustomHomesInc/  LinkedIn - https://www.linkedin.com/in/mark-williams-968a3420/  Houzz - https://www.houzz.com/pro/markdwilliamscustomhomes/mark-d-williams-custom-homes-inc

The boys discuss their ideal mode of transportation for navigating Los Angeles.   For simple, online access to personalized and affordable care for Hair Loss, ED, Weight Loss, and more, visit https://Hims.com/SUPERMEGA Featured products include compounded drug products, which the FDA does not approve or verify for safety, effectiveness, or quality. Prescription required. See website for full details, restrictions, and important safety information. Individual results may vary. Based on studies of topical and oral minoxidil and finasteride.  Sign up for your $1 per month trial today at https://Shopify.com/super If you're 21 or older, get 40% OFF your first order @IndaCloud with code SUPERMEGA at https://inda.shop/SUPERMEGA! #indacloudpod Follow Matt: @matthwatson Follow Ryan: @elirymagee Follow the show: @supermegashow Learn more about your ad choices. Visit podcastchoices.com/adchoices

This episode could change the way you think about boundaries, pricing, and what's actually possible in your coaching practice. You'll hear from a married couple regarding their initial resistance to working together, establishing healthy boundaries, defining roles and responsibilities, and the critical importance of pricing yourself correctly. My guests offer practical wisdom on maintaining work-life balance, protecting personal time, and thriving in both marriage and business through intentional communication and mutual respect. What have they learned that could help YOU, whether you work with your spouse or not? Join us to find out!Robert and Kay Lee Fukui are the co-founders of i61 Inc., a business consulting company that helps married entrepreneurs achieve better work-life balance by structuring their businesses for scalability, while also freeing up precious time to invest in their marriages and families.Robert has 25 years of successful sales and marketing experience with companies like Coca-Cola, Novartis Pharmaceuticals, and Bristol-Myers Squibb. He played an instrumental role in launching six major brands and is the recipient of national sales and leadership awards. His business acumen allows him to help family businesses become more profitable, efficient, and sustainable. Kay worked in the banking industry for many years and in her family business as the operationsmanager for 10 years before meeting Robert, the love of her life. She understands the highs and lows of running a family business and the sacrifices owners make–often at the expense of marriage and family. Her passion is to see marriages flourish while building a profitable business and to help entrepreneurial couples understand that marriages and families don't have to be sacrificed for business. Together, they have developed an innovative consulting program, Thriving in Tandem™, which equips the married entrepreneur to build a thriving marriage AND a prosperous business. They have authored the book Tandem: The Married Entrepreneurs' Guide for Greater Work-Life Balance and host the podcast Thriving in Tandem.Show Highlights:Working together with your spouse ALL the time: Can that really work?Time management, boundaries, and defining your lane of geniusFreeing up time through ADE: automate, delegate, and eliminateSetting priorities and learning to say NOKay Lee's mindset as a third-generation entrepreneur who is learning to be more efficientEmbracing change, intentional communication, and learning to pivotSet up a structure so you don't overextend yourself. (Your boundaries deserve to be honored!)When you are with your family, BE with your family.The ONE business decision that will make more money and give you time back: raise your pricesKey takeaways from Robert and Kay Lee:Robert: “If it feels like your business is running you instead of you running your business, fix it. Step back and evaluate.”Kay Lee: “Are you working in your zone of genius? If not, how can you do that? Do more of what you love!”Resources:Connect with Robert and Kay Lee FukuiWebsite (Find your free gift!), Tandem: The Married Entrepreneurs' Guide for Greater Work-Life Balance, Thriving in Tandem podcast, Facebook, InstagramConnect with MegExplore the STaR Coach Show Mentor Program. We are enrolling NOW for this summer!Subscribe to the STaR Coach Show YouTube Channel!Explore over 480 past episodes and other helpful resources at www.STaRcoachshow.com.Mentioned in this episode:Enroll More Clients: Clarity SprintDo you love coaching, but when it comes to enrolling clients, writing your bio, or posting online, you freeze? Or fall into “coach speak” that doesn't actually connect? That's not a you problem. It's a messaging problem—and it's costing you clients. Join me for my free, live five-day experience: Enroll More Clients: Clarity Sprint. From March 16–20 at 9 a.m. Central, I'll help you get crystal clear on your ideal client, refine your message so it actually resonates, and create a confidence statement that makes booking a call the obvious next step. No fluff, just clarity, you can use immediately. Grab your free spot at: https://starcoachshow.com/5dayEnroll More Clients: Clarity Sprint

Caleb talks with Brad and Tammy Miller, the founders of Tandem Marriage. Drawing from their experience running a seven-figure counseling practice and their own 41-year marriage, the Millers discuss how professional success can lead to a "slow drift" that distances spouses. They emphasize that high-achieving business owners often fall into a "provider trap," mistakenly believing financial stability is the only way to show love while neglecting emotional connection. To counter this, they advocate for extreme intentionality, urging couples to remain curious about one another and prioritize their relationship as a unified team. The episode highlights various resources available at tandemarriage.com, including a video toolbox and mentorship advice, to help couples move from a mediocre marriage to a thriving one. Key Takeaways: Commit to being intentional in your relationship every day to prevent the natural "slow drift" that occurs when life and business become overwhelming. Prioritize a loving relationship with your spouse as the greatest gift you can give your children, providing them with a foundation of security and a healthy model for their own lives. Develop self-awareness during conflicts by pausing to ask yourself if there is any truth in what your spouse is saying before you react defensively. Ensure that your role as a financial provider never usurps your responsibility to be an emotionally present and supportive partner at home. Regularly seek outside guidance through mentors, coaching, or educational resources to keep your marriage thriving as you navigate different seasons of life and business. Connect with Auman Landscape